Last week we concluded our master’s edition 2017-2018. After nine months of hard work, board of professors, students and managing directors of the Biotechnology Business Institute joined together the presentation of the final projects in the framework of the first year of the educational agreement Discover & Transfer.

The new educational model, presented by the Institute, is based on real intellectual property projects and drug candidates, which makes possible a new way of learning focused on practical aspects. The collaboration agreements with the Biomedical Research Institute of Barcelona (IRB Barcelona) and the Fundació Bosch i Gimpera (FBG), both international reference research centers in Barcelona had allowed our students to work with current investigations of the institutions and follow up their discoveries in real plans.

The final thesis defense involved the whole work of the students since they started last October working on the feasibility plans, and the researchers and innovation managers didn’t want to miss the presentations.

Throughout the academic course, there had been different meetings between the students and the researchers to follow up together the different stages of the business plans, drug developments plans and brand plans from the different specializations. In addition, an expert jury, integrated by a group of professionals from the sector, where responsible of its evaluation and final remarks.

Finally, that evening, as part of their graduation, the students took part during the Summer Charity Cocktail. As part of its commitment with innovation and entrepreneurship, the Biotechnology Business Institute and Richi Entrepreneurs presented the first Childhood Cancer Innovation Award, a charity event in favor of pediatric investigation.

Latest news

The Biotechnology Business Institute closes the 5th edition of the Scientific MBA in Lifesciences with a great success and four projects developing drug candidates.

Four drug candidates targeting three indications, Breast Cancer, Chron’s Syndrome and NASH (nonalcoholic steatohepatitis), were presented by our students in the closing ceremony of the Scientific MBA’s as a result of a year developing different intellectual properties for potential new treatments

BBI Case Study in International Strategy. Aortyx, a success case in early stage funding for medical device focus in aortic disease

During the evening of the BBI Open Day a study case in early stage funding was presented by Jordi Martorell, Patrick O’Brien, Lifesciences consultant, and William Hariri, Director at Alira Health. The main objective of the evening was to understand how to develop and international strategy for medical devices.

The Biotechnology Business Institute closes the first BBI Open Day with great success inspiring young scientific professionals

The importance of scientific profiles in a society based in innovation and how their professional development in management can contribute to drug discovery, were some of the main topics presented during the BBI Open Day 2019

The first 2019 BioInternational Seminar is a success and gain interest between scientific profiles with vision in drug discovery

International experts shared their experience and knowledge in the pharmaceutical industry and the biotechnology sector over an evening with young scientific profiles developing their career in the drug discovery field

Filter by category